CLSA analyst Andrew Paine raised the price target on ResMed (RMD:AU) (NYSE: RMD) to AUD35.00 (from AUD34.40) while maintaining a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE